StockTipsArenaBeta

BUY Ajanta Pharma Limited — Kiran Jani, Jainam Broking

BUYAjanta Pharma Limited
Ajanta Pharma share price target & all analyst calls

byKiran Jani, Jainam BrokingHorizon: 1–3 months26 May 2026via Business Today

Entry₹3,100.4Inferred
Target₹3,600
Total upside +16.11% (call closed)
Stop loss₹2,100-32.27% risk
Exit₹3,60013 Aug 2026, 12:08 pm
Target hit+16.11%0.00%upside left
Follow Kiran Jani for new calls(17% target hit, 12 closed calls)Get alertsWatch AJANTPHARM for new buy/sell callsGet alertsSee 45 active Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 13 Aug 2026
6 supporting2 neutral4 opposing
Supports the BUY call (6)

4 advisors have active long-term BUY calls on this stock, with 3 issued in the last 14 days

Advisor consensus · adjacent horizon·10 Aug · 3d ago

Q1 Results Today Highlights: Swiggy narrows loss, Bajaj Finance, M&M, Gillette, Vedanta, Vedanta Aluminium, Ajanta Pharma, IRFC, ICRA, Niva Bupa profit rise, Hyundai PAT down; Torrent Pharma PAT up 3.3%; Tata Steel profit jumps 19%, NSDL's PAT up 9%

NewsHbl·30 Jul · 2w ago

(opens in new tab)

Dividend Alert: Ajanta Pharma Announces Interim Dividend — Check Record Date, Payout Date

NewsNdtv-Profit·30 Jul · 2w ago

(opens in new tab)

Ajanta Pharma Q1 profit jumps 31% on strong US sales; declares ₹32 dividend

NewsCnbc-Tv18·30 Jul · 2w ago

(opens in new tab)

Cipla, Ajanta Pharma to Alkem Laboratories: Pharma stocks rise amid weak trends on Dalal Street

NewsLivemint·20 Jul · 3w ago

(opens in new tab)
Neutral / worth noting (2)

Ajanta Pharma Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

NSE · Outcome of Board Meeting·30 Jul · 2w ago

(opens in new tab)
Weighs against the BUY call (4)

Ajanta Pharma షేర్ ధర పడిపోయింది.. కారణం ఇదే!

NewsGoogle News·5 Aug · 1w ago

(opens in new tab)

Ajanta Pharma Share: डिविडेंड रिकॉर्ड डेट पर **3%** गिरा शेयर, जानिए क्या है वजह

NewsGoogle News·5 Aug · 1w ago

(opens in new tab)

Ajanta Pharma Share Price: डिव्हिडंडमुळे शेअर पडला 3%, पण ही आहे खरी बातमी!

NewsGoogle News·5 Aug · 1w ago

(opens in new tab)

Trump's tariff policy: Abbott India, Ajanta Pharma to Alembic — pharma stocks crash up to 4%

NewsLivemint·24 Jul · 3w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Ajanta Pharma

All analyst calls on Ajanta Pharma

More from Kiran Jani, Jainam Broking

Every call and its outcome